Scroll To Top
Search by Speciality

Metabolic & Endocrine Disease Summit – MEDS West 2018

Wyndham San Diego Bayside * | San diego, USA
From 295 to 495 USD
Event Preview
13
Days Left
For the
Event
Title: Metabolic & Endocrine Disease Summit - MEDS West 2018
Specialty: Internal Medicine
Dates: From Aug, 1, 2018 to Aug, 4, 2018
Location: San diego, USA
Type: Summit
Registration Cost: From 295 to 495 USD
Event Tools
  • Add to Favorites
  • Notify me by email
  • Claim this event
Add to my Calendar
Aug
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for San Diego, Usa.
General Info
Event Venue:

Wyndham San Diego Bayside *

San Diego, USA Visit the Venue to read more
Currency:
USD
Accreditation:

-

The Metabolic and Endocrine Disease Summit is designed for NPs, PAs, RNs, CDEs, and other clinicians involved in the diagnosis and management of metabolic and endocrine disorders.


Learning Objectives

Diagnose metabolic and endocrine diseases

Treat the growing number of patients affected by these diseases

Describe ways to fill the void created by the national shortage of endocrinologists

Continuing Medical Education

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 24.25 contact hours. Designated for 9.5 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.


Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Global Academy for Medical Education, Inc. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.


Physician Credit Designation

The University of Cincinnati designates this Live Activity for a maximum of 24.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Assistants Credit Designation

The American Academy of Physician’s Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME.

Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

Welcome to Metabolic & Endocrine Disease Summit (MEDS)

Why Attend the Metabolic & Endocrine Disease Summit MEDS?

To elevate your competence and confidence on the diagnosis and treatment of metabolic and endocrine diseases

To enhance your ability to treat the growing number of patients affected by these diseases

To earn 24.25 CE/CME Credits including 9.5 contact hours of pharmacotherapy content in high demand areas of practice

To attend an optional interactive Insulin Workshop

To network with your fellow primary care clinicians

To empower yourself to fill the void created by the national shortage of endocrinologists

To get the most value for your educational dollar. At MEDS, your breakfast (Wed-Sat) and lunch (Wed-Fri) is included with your registration!

To take part in a highly acclaimed educational activity designed by and for NPs and PAs


SUSPECTING PITUITARY DISORDERS “WHAT'S NEXT?”

Ji Hyun (CJ) Chun, PA-C, BC-ADM

Describe medically relevant anatomy and physiology of pituitary gland

Outline appropriate evaluation of pituitary adenomas and function

Describe common functional pituitary adenomas (prolactinoma, acromegaly)

Acknowledge signs and symptoms of hypopituitarism

 

ADRENAL FORECAST: FOGGINESS GIVING WAY TO GREAT VISIBILITY (PART 1)

Scott Urquhart, PA-C, DFAAPA

Analyze etiologies, clinical presentation, work-up, and management of primary adrenal insufficiency

Investigate the clinical presentation, work-up, and treatment of hypercortisolemia as it relates to Cushing’s syndrome / disease

 

ADRENAL FORECAST: FOGGINESS GIVING WAY TO GREAT VISIBILITY (PART 2)

Scott Urquhart, PA-C, DFAAPA

Examine the presentation of pheochromocytoma and implement a simple work-up for the diagnosis and proper referral

Explore incidentally discovered adrenal adenomas with respect to initial discovery, imaging, work-up, treatment, and follow-up

 

NEW THERAPIES FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA: HOW TO USE THEM?

Joyce L. Ross, MSN, CRNP, CLS, FNLA, FPCNA

Differentiate the 2013 AHA/ACC guideline recommendations from those of the NLA for the management of hypercholesterolemia

Describe the mechanism of action, safety, efficacy, and differences between PCSK9 inhibitors small molecule conventional lipid-lowering therapies

Apply the latest clinical trial data and guideline recommendations to devise treatment regimens for patients with hypercholesterolemia to achieve LDL-C control

 

OBESITY: THE LATEST SKINNY ON THE FAT ATTACK

Christine Kessler, MN, CNS, ANP, BC-ADM, CDTC, FAANP

Review the latest epidemiologic factors likely influencing the rise of obesity in this country

Describe various interconnections between fat (& selected adipokines), gut incretins & and neuropeptides in relation to satiety, calorie utilization, addictions and mood

Correlate selected obesity co-morbidities to abnormal adipokine release and enteroendocrine function

Relate the physiologic impact of various behavioral, pharmacologic and surgical intervention strategies in obesity prevention and treatment

Review the efficacy of common over-the-counter weight loss remedies

 

NUMB TOES AND OTHER WOES: DIABETIC PERIPHERAL AND AUTONOMIC NEUROPATHIES

Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC

Describe the microvascular complications of retinopathy and autonomic neuropathy that affect patients suffering from diabetes mellitus

Identify the clinical manifestations of these complications

Apply current screening recommendations to ensure patients receive timely care

 

VASCULAR RISK: WHAT'S REALLY IMPORTANT?

Joyce L. Ross, MSN, CRNP, CLS, FNLA, FPCNA

Recall the relationship of elevated glucose to cardiovascular disease (CVD)

State how inflammatory risk factors are contributory to CVD

Discuss lipid target stratification in those with elevated glucose levels or DM

Articulate the role of hypertension to increased CVD

 

CASE STUDIES IN TYPE 2 DIABETES: YOU, ME, AND YOUR A 1 C – ACHIEVING GOALS TOGETHER

Presenters: Scott Urquhart, PA-C, DFAAPA

Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC

Review the current ADA/EASD, and AACE guidelines for pharmacologic management of diabetes

Critique the pharmacologic options with their expected A1C reduction, side effects profiles and safety concerns

Apply a glucose-centric approach to incorporate oral and non-insulin injectable agents in the treatment of patients with type 2 diabetes

Demonstrate how a patient-centric approach promotes empowerment and positive outcomes

 

INSULIN OVERVIEW: WHAT’S ON THE MENU? TACKLING THE DIFFERENCES

Davida F. Kruger, MSN, APRN-BC, BC-ADM

Participants will be able to identify a variety of insulin options available to treat people with diabetes

Participants will be able to verbalize the difference in potency between u-100 insulin, and u-500 insulin

Participants will be able to identify insulin available in vials and insulin pens

Participants will be able to verbalize insulin on the horizon

Participants will be able to effectively write a prescription for insulin

Speakers/Faculty:

Ji Hyun (CJ) Chun, PA-C, BC-ADM

Physician Assistant

OptumCare Medical Group

Laguna Niguel, California

President

American Society of Endocrine PAs (ASEPA)

Adjunct Faculty

A.T. Still University

Mesa, Arizona

Click here for bio



Donna Jornsay, MS, CPNP, CDE, CDTC, BC-ADM

Diabetes Program Manager/Clinical Specialist

Mills-Peninsula Medical Center, Sutter Health

Burlingame, California

Click here for bio



Davida Kruger, MSN, APRN-BC, BC-ADM

Diabetes Specialist

Division of Endocrinology, Diabetes and Bone & Mineral Disorders

Henry Ford Health System

American Diabetes Association® (ADA)’s 2017 recipient of the Outstanding Educator Award

Detroit, Michigan


Click here for bio


Click here for the webcast of Davida's Outstanding Educator in Diabetes Award Lecture the 2017 ADA Annual Meeting.



Ellen D. Mandel, DMH, MPA, MS, PA-C, RDN, CDE

Clinical Professor

Pace University

Lenox Hill Hospital Physician Assistant Program

New York, New York

Click here for bio



Rick Pope, MPAS, PA-C, DFAAPA, CPAAPA

Dept. of Rheumatology

Western Connecticut Medical Group

Adjunct Professor

Quinnipiac University

University of Bridgeport

New York Institute of Technology

Danbury, Connecticut

Click here for bio



Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC

Director, Riverside Diabetes Center

Riverside Medical Associates

Adjunct Assistant Professor

Uniformed Services

University of the Health Sciences

Bethesda, Maryland

Click here for bio



Joyce L. Ross, MSN, ANP, CLS, CRNP, FPCNA, FNLA

Diplomate Accreditation Council For Clinical Lipidology

Past President Preventive Cardiovascular Nurses Association

President National Lipid Association

Consultative Education Specialist, Cardiovascular Risk Intervention

University Of Pennsylvania Health System

Philadelphia, Pennsylvania

Click here for bio



Chris Sadler, MA, PA-C, CDE, DFAAPA

Past President, American Society of Endocrine Physician Assistants

Diabetes and Endocrine Associates

La Jolla, CA

Click here for bio



R. Mimi Secor, DNP, FNP-BC, NCMP, FAANP

Visiting Scholar, Boston College

President Emerita/Senior Advisor, NPACE

Just Us Women

Attleboro, Massachusetts

Coach Kat and Dr Mimi

Click here for bio



Kim Zuber, PA-C, DFAAPA, FNKF

Physician Assistant

American Academy of Nephrology PAs

Oceanside, California

Click here for bio

Registration Needs updating Register Now
Currency:

USD

Registration Cost
Type
Early Registration

2018-02-09
Late Registration From: 2018-02-10 To: 0--
On site Registration
NPs/PAs/Other Clinicians
325
395
495
PCMG/ASEPA member
295
345
395

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

Accommodation
Accommodation:

MEDS West Venue


Wyndham San Diego Bayside

San Diego, California


The 2018 Metabolic & Endocrine Disease Summit (MEDS West) will take place at the Wyndham San Diego Bayside, in San Diego, California, where we have arranged discount rates of just $179 a night for MEDS participants.


The Wyndham San Diego Bayside is located along San Diego’s waterfront — close to the most popular attractions the city has to offer. Free shuttle service available to many local attractions, such as the Gaslamp Quarter and Seaport Village.


To make your reservation, click here: https://aws.passkey.com/go/MEDS2018  or call 1(866)781-2632 and identify yourself as a Metabolic & Endocrine Disease Summit attendee to receive the MEDS special room rate.


Discount room rates expire Monday, July 2, but we urge you to make your arrangements as soon as possible as our room block will sell out.


MEDS East Venue 


Caribe Royale

8101 World Center Dr

Orlando, Florida, 32821


This all-suite get-away is located just 1.5 miles from Walt Disney World. 

Parking at the Caribe is FREE for MEDS attendees.


The 2018 Metabolic & Endocrine Disease Summit (MEDS East) will take place at the Caribe Royale in Orlando, Florida, where we have arranged discount rates of just $159 a night ($259 a night for a 2 bedroom villas with kitchen) for MEDS participants.


To make your reservation, call (888) 258-7501 and identify yourself as a Metabolic & Endocrine Disease Summit attendee to receive the MEDS special room rate.


Discount room rates expire Monday, September 10, but we urge you to make your arrangements as soon as possible as our room block will sell out.

Scientific Content Up to Date
Submission Info
Sponsors Exhibitors
General Info

Exhibit & Sponsor Information


 


Why Support the Metabolic and Endocrine Disease Summit (MEDS)?


Each MEDS meeting gives you face-to-face contact with more than 300 NPs and PAs in primary care, providing you ample opportunity to educate and build relationships in this growing sector of healthcare

Keep NPs and PAs current with the latest pharmacologic and medical device advances in treating patients with metabolic and endocrine diseases

Interact with NPs and PAs on the frontlines of treating patients with metabolic and endocrine diseases to identify areas where new therapies could improve patient outcomes.

MEDS also now accepts industry-sponsored abstract submissions for MEDS poster sessions. Please click here for more information.


For more information contact: Guy Pawlak at 973-206-2328 or gpawlak@frontlinemedcom.com

Exhibition Consensus
Contact
Organising Agency

Mary Palermo 

561-777-9426

m.palermo.globalacademycme@gmail.com


Kathy Wenzler 

973-206-8092

k.wenzler@globalacademycme.com

Event map
Revelant Events